Status:
UNKNOWN
Study of Tramadol Addiction Impact on Dental Anesthesia Success Among Algerian Males
Lead Sponsor:
Future University in Egypt
Conditions:
Dental Procedure
Eligibility:
MALE
18-65 years
Phase:
PHASE4
Brief Summary
Dental anesthesia is considered by far one of the main procedures in dentistry; the performance of a good dental anesthesia with a correct technique is paramount in controlling pain, facilitating the ...
Detailed Description
Tramadol is an FDA-approved medication for pain relief indicated mainly for moderate to severe pain, it is an opioid with 6 hours Half-Life and different dosages as 50mg, 100mg, 200mg and 300mg. Due t...
Eligibility Criteria
Inclusion
- Males
- ≥18 years
- With no comorbid conditions (HTN, Diabetes \& Epilepsy)
- Tramadol addict (regular tramadol user)
Exclusion
- Females
- ˂ 18 years
- With comorbid conditions (HTN, Diabetes \& Epilepsy)
- ≥ 65 years males
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05418504
Start Date
May 1 2022
End Date
August 1 2022
Last Update
June 16 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Doaa El-Bohy
Cairo, Egypt, 11817
2
Future University in egypt
Cairo, Egypt